Aleksandra  Śmigiel

Aleksandra Śmigiel

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
AŚAleksandra Śmigiel
Aleksandra Śmigiel
ZMZuzanna Mularczyk
Zuzanna Mularczyk
POPiotr Tadeusz Oleksy
Piotr Tadeusz Oleksy
MRMagdalena Reclik
Magdalena Reclik
EGEwa Góralczyk
Ewa Góralczyk
JSJoanna Siuda
Joanna Siuda
Introduction: The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represents a significant global public health challenge. While respiratory symptoms dominate, the virus's impact on other systems, particularly the central nervous system (CNS), has gained increasing attention. SARS-CoV-2 demonstrates tropism for Angiotensin-Converting Enzyme 2 (ACE2) receptors, expressed in the olfactory epithelium, lungs, endothelium, kidneys, enterocytes, and neurons, contributing to neurological manifestations observed during the acute phase of the disease. Materials and Methods: A literature review was conducted using PubMed, Scopus, Web of Science, and ScienceDirect databases. Keywords included: COVID-19, Post Acute COVID-19 Syndrome, SARS-CoV-2 Virus, Neurological Manifestations, and Central Nervous System Viral Diseases. A total of 58 articles were selected for analysis based on relevance and quality of evidence regarding neurological symptoms and complications associated with COVID-19. Basic Results: The acute phase of COVID-19 frequently involves neurological symptoms such as frontal and holocranial headaches, dizziness, gustatory and olfactory dysfunctions, and alterations in consciousness. Severe complications, though less common, include encephalitis, ischemic and hemorrhagic stroke, cerebral venous thrombosis, and myelitis. These conditions often present as altered mental status, seizures, aphasia, headaches, or focal deficits, contributing substantially to patient morbidity and mortality. Conclusions: Neurological symptoms and complications constitute a significant aspect of COVID-19, highlighting the virus's potential to affect the CNS. While severe complications are rare, their profound impact on prognosis underscores the importance of early recognition and management. Further research is essential to understand the pathophysiology and optimise therapeutic approaches for affected patients.

1 January 2025 in Postępy Psychiatrii i Neurologii
Verified
Journal Article
Open access
PDF file
MRMichalina Rzepka
Michalina Rzepka
MTMateusz Toś
Mateusz Toś
POPiotr Tadeusz Oleksy
Piotr Tadeusz Oleksy
MRMagdalena Reclik
Magdalena Reclik
ZMZuzanna Mularczyk
Zuzanna Mularczyk
JSJoanna Siuda
Joanna Siuda
Purpose Myelin oligodendrocyte glycoprotein-associated disease (MOGAD) is an autoimmune demyelinating disorder of the central nervous system, presenting as optic neuritis, transverse myelitis, or acute disseminated encephalomyelitis. In 2023, international diagnostic criteria were established,...

19 March 2026 in Journal of Pre-Clinical and Clinical Research
Verified
Journal Article
Open access
PDF file
ZMZuzanna Mularczyk
Zuzanna Mularczyk
POPiotr Tadeusz Oleksy
Piotr Tadeusz Oleksy
MTMaciej Tenderenda
Maciej Tenderenda
AŚAleksandra Śmigiel
Aleksandra Śmigiel
MRMichalina Rzepka
Michalina Rzepka
JSJoanna Siuda
Joanna Siuda
Introduction and objective: Myelin oligodendrocyte glycoprotein-associated disease (MOGAD) has emerged as a distinct entity among demyelinating diseases of the central nervous system (CNS). It most commonly manifests around the age of 30 and affects both sexes genders equally. MOGAD includes a...

11 May 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MTMaciej Tenderenda
Maciej Tenderenda
ZMZuzanna Mularczyk
Zuzanna Mularczyk
BBBartosz Buczkowski
Bartosz Buczkowski
KNKrzysztof Nowakowski
Krzysztof Nowakowski
AŚAleksandra Śmigiel
Aleksandra Śmigiel
ABAleksandra Broniak
Aleksandra Broniak
Introduction The role of dietary factors in modulating immune function and influencing the risk and progression of autoimmune diseases has recently gained increasing attention. Western-style dietary factors, rich in processed foods, saturated fatty acids, and refined sugars, have been implicated in promoting systemic low-grade inflammation and contributing to gut dysbiosis, while anti-inflammatory diets may offer protective benefits. Better understanding of diet and its impact on the immune system may offer new therapeutic avenues to explore in the near future. Materials and Methods A literature review was performed using four major scientific databases: PubMed, Elsevier, Web of Science, and Scopus. A total of 72 research and review articles relevant to the topic were selected based on predefined inclusion criteria. The selection criteria were based upon key words: autoimmune diseases, diet, inflammation, gut microbiota, micronutrients, Western diet, Mediterranean diet, omega-3 fatty acids. Basic Results Diets high in processed foods, saturated fatty acids, and high-glycemic index foods contribute to the development and maintenance of chronic inflammation, oxidative stress, and gut microbiota dysbiosis. Conversely, diets rich in polyphenols, flavonoids, fibers, and omega-3 fatty acids, promote immune tolerance and maintain the balance between anty- and proinflammatory factors. Conclusions Nutritional interventions may serve as supportive strategies for prevention and management of autoimmune diseases. Understanding dietary risk factors and implementing targeted nutritional modifications in the future could improve patients’ outcomes.